Covered recipient · General Payments record
DEBORAH MARIE STEPHENS
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$81,700.65
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $16,062.50 | 7 |
| Travel and Lodging | $960.08 | 3 |
| Food and Beverage | $334.02 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $9,095.05 | 11 |
| Acerta Pharma LLC | $4,642.50 | 3 |
| BeiGene USA, Inc. | $1,889.05 | 2 |
| E.R. Squibb & Sons, L.L.C. | $1,730.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $365.12 | 05/31/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106161249 | CMS |
| ABBVIE INC. | $131.29 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161251 | CMS |
| ABBVIE INC. | $552.96 | 06/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106161253 | CMS |
| ABBVIE INC. | $3,750.00 | 08/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106161255 | CMS |
| ABBVIE INC. | $42.00 | 09/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106161257 | CMS |
| ABBVIE INC. | $50.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161259 | CMS |
| ABBVIE INC. | $15.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161261 | CMS |
| ABBVIE INC. | $50.00 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161263 | CMS |
| ABBVIE INC. | $13.68 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106161265 | CMS |
| ABBVIE INC. | $1,500.00 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106161267 | CMS |
| ABBVIE INC. | $2,625.00 | 12/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106161269 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,712.50 | 03/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104240369 | CMS |
| AstraZeneca Pharmaceuticals LP | $60.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104425903 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,870.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105505964 | CMS |
| BeiGene USA, Inc. | $1,875.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120857799 | CMS |
| BeiGene USA, Inc. | $14.05 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120857797 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,730.00 | 02/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101655261 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.